The invention relates to compounds of the general formula (I) in which: the pyrrolopyridine node is optionally substituted at the 4, 5, 6 and / or 7 carbonated position by one or more identical or different X substituents selected from a hydrogen or halogen atom or a C1C6-alkyl, C3-C7- cycloalkyl, C3-C7cycloalkyl-C1C6-alkylene, C1C6-fluoroalkyl, C1C6-alkoxyl, C3-C7- cycloalkoxyl, C3-C7-cycloalkyl-C1C6-alkylene-O-, C1C6-fluoroalkoxyl, cyano, C1-C6- thioalkyl, -S(O)-C1C6-alkyl, -S(O)-C2-C6-alkyl, SF5, C(O)NR1R2, SO2NR1R2, nitro, NR1R2, OCONR1R2, NR3COR4, NR3CONR1R2, NR3SO2R5, NR3SO2NR1R2, aryl-C1C6- alkylene, heteroaryl-C1C6-alkylene, aryl or heteroaryl group, the aryl and heteroaryl being optionally substituted; Z1, Z2, Z3, Z4 independently represent a nitrogen atom or a C(R6) group, one of which at least corresponds to a nitrogen atom and one of which at least corresponds to a C(R6) group; Z in a cyclic amine bound by the nitrogen atom or cyclic amine bound by the nitrogen and of the formula NraRb; wherein the compounds can be in the base state or in the state of an addition salt for an acid, or in a hydrate or solvate state. The invention also relates to a method for making the same and to the use thereof in therapy.